Observational studyCancer medicine2023

Immune-related adverse events and outcomes among pan-cancer patients receiving immune checkpoint inhibitors: A monocentric real-world observational study.

Xiaoxiao Ge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.